Intellectual Property

  • May 14, 2026

    IP Atty Gets $4.5M Over Fake Child Abuse Allegations

    A California state jury has hit the CEO of a sobriety app with a $4.5 million verdict over claims he made a false child abuse report against the mother of his child, a Los Angeles intellectual property attorney, in a bid to secure child support and full custody, according to the counsel for the mother.

  • May 14, 2026

    Squires Walks Back 5 More IPR Grants Over Inconsistent Args

    U.S. Patent and Trademark Office Director John Squires has reversed earlier decisions granting five petitions for patent review, citing what he called the challengers' inconsistent positions in parallel proceedings and explaining that four petitions he denied in previous bulk orders were also rejected for the same reasons. 

  • May 14, 2026

    Squires Ends IPR After Railway Co. Surrenders Patent Claim

    U.S. Patent and Trademark Office Director John Squires has de-instituted a Patent Trial and Appeal Board review after National Steel Car Ltd. disclaimed the only parts of its patent the board thought could be invalid, saying they should "be treated as though they never existed."

  • May 14, 2026

    States Eye AI Ownership Laws To Fill Federal IP Gaps

    States are beginning to test whether they can fill a gap left by federal copyright and patent law for works created with artificial intelligence, with Arkansas adopting a first-of-its-kind ownership rule for generative content and lawmakers elsewhere weighing their own proposals.

  • May 14, 2026

    GoDaddy Overcomes Willfulness Finding From $170M Verdict

    A Delaware federal judge on Thursday found that GoDaddy had not willfully infringed two website patents held by Express Mobile Inc., thus sparing the company a verdict greater than the $170 million a jury found but still assessing prejudgment and postjudgment interest.

  • May 14, 2026

    Apple Drops Bid To Transfer Fintiv Suit Due To Albright Exit

    Apple Inc. has abandoned its request to transfer Fintiv Inc.'s trade secret theft and racketeering lawsuit from Georgia to Texas, citing U.S. District Judge Alan Albright's decision to leave the bench in the Western District of Texas.

  • May 14, 2026

    House Panel Backs Bill To Recast Copyright Office Oversight

    A U.S. House committee Thursday unanimously advanced a bill that would change how the Copyright Office chief is selected, requiring congressional leaders to recommend candidates while allowing the president to make the final selection — a shift that would give both branches of government a more direct role in choosing the agency's leadership.

  • May 14, 2026

    Fed. Circ. Won't Eye Part Of Columbia's Axed $600M IP Win

    The Federal Circuit said Thursday it won't take up Columbia University's request for it to reconsider a portion of a panel decision by the appellate court that discarded a nine-figure patent judgment against the maker of Norton antivirus software.

  • May 14, 2026

    Fed. Circ. Upholds Mercedes, VW Headlight Patent Wins

    The Federal Circuit on Thursday rejected an Israeli inventor's attempts to revive claims in a trio of patents covering adaptive headlights, handing wins to German automakers Mercedes-Benz, Volkswagen and Porsche.

  • May 14, 2026

    OpenAI Seeks To Overturn Injunction In 'IO' TM Fight

    OpenAI is urging a California federal judge to overturn a preliminary injunction barring the company from using "IO" as a trademark for AI hardware, arguing it has abandoned all federal applications for the mark and has no plans to use it.

  • May 14, 2026

    United Rentals, Ex-Worker Strike Deal In Noncompete Suit

    United Rentals Inc. on Thursday asked a Connecticut federal judge to approve a permanent injunction blocking a former North Carolina salesperson from working for a competitor within 100 miles of United's Raleigh branch office through mid-January 2027, ending a 4-month-old noncompete suit.

  • May 14, 2026

    Takeda Cashed In From Delay Of Generic IBS Drug, Jury Told

    Drug buyers urged a Massachusetts federal jury on Thursday to find that Takeda Pharmaceuticals conspired with another drugmaker to keep a generic version of anticonstipation drug Amitiza off the market in order to boost its own profits. 

  • May 14, 2026

    Squires Ends AMD Challenges At PTAB Over Sotera Issues

    U.S. Patent and Trademark Office Director John Squires has terminated reviews of three data processing patents challenged by Advanced Micro Devices Inc. after finding AMD violated a stipulation to limit its invalidity arguments in court.

  • May 14, 2026

    BeiGene Must Face AbbVie's Chemical Trade Secret Claims

    An Illinois federal judge has denied oncological research company BeiGene's request to escape claims from AbbVie Inc. that it poached a retired scientist to obtain trade secrets related to a certain chemical compound, saying BeiGene failed to back up its arguments.

  • May 14, 2026

    Sterne Kessler, Thomson Reuters Launch Patent Eligibility AI Tool

    Intellectual property boutique Sterne Kessler Goldstein & Fox PLLC announced it has partnered with Thomson Reuters Corp. to develop an artificial intelligence workflow within CoCounsel Legal to analyze patent eligibility under Section 101.

  • May 13, 2026

    Toyota Foundation Accused Of 'Ugly Injustice' In IP Theft Suit

    A Toyota mobility systems foundation stole trade secrets from a small Zimbabwean social enterprise by inducing the enterprise to share its proprietary mobility solutions through a joint venture agreement before excluding the enterprise from a "Smart Village" program they collaborated on, the enterprise has alleged in California federal court.

  • May 13, 2026

    Judge Says LegalForce Must Pay $93K After Losing TM Suit

    A California federal judge on Wednesday ordered LegalForce RAPC Worldwide PC to pay nearly $93,000 in fees and costs to the company that operates LawFirms.com, finding the case to be exceptional because LegalForce alleged facts it knew were false and took steps to obscure other facts that showed its case was meritless.

  • May 13, 2026

    Fed. Circ. Won't Save Actelion's Suit Over Hypertension Drug

    The Federal Circuit on Wednesday upheld a lower court's rejection of Actelion Pharmaceuticals' patent case against Viatris Inc. over its planned generic version of Actelion's hypertension drug, finding no issues with the court's approach to pH measurement in the patent.

  • May 13, 2026

    Squires Hits Pause On Unpopular Examiner Sign-Off Policy

    The U.S. Patent and Trademark Office director has paused a policy requiring that supervisory patent examiners sign off on some first actions by examiners who have signatory authority, a policy that's been unpopular with examination staff since its rollout in the fall, Law360 has learned.

  • May 13, 2026

    Big Fish Games Buyer Evading Royalty Duties, Studio Claims

    The new owner of Seattle-based desktop game publisher Big Fish Games has been accused of attempting to illegally rewrite deals with a studio that helped develop many of its titles to avoid paying royalties and revoke mobile distribution rights, according to a fresh lawsuit in Washington state court.

  • May 13, 2026

    Nvidia, SK Hynix, Kioxia Face Memory Patent Litigation

    A Texas-based technology company has launched new patent infringement suits at district courts in the Lone Star State and Delaware as well as at the U.S. International Trade Commission, targeting companies such as Nvidia Corp., Corsair Gaming and Western Digital.

  • May 13, 2026

    Fed. Circ. Backs Google PTAB Wins That Moot $12M Verdict

    The Patent Trial and Appeal Board properly invalidated all claims of the five Flypsi Inc. telecom patents Google LLC was found to infringe, the Federal Circuit said Wednesday.

  • May 13, 2026

    Event Company Says NFL's Lions Can't Block TM Suit

    A Michigan events management company on Wednesday pushed back on the Detroit Lions' request for a Michigan federal judge to toss their trademark infringement suit, arguing the NFL team did nothing to disprove U.S. Events' claim that the Lions used their protected "Motor City Muscle" slogan to promote their team jerseys without their permission.

  • May 13, 2026

    Shutterstock Inks $35M Deal In FTC's Autorenewal Suit

    Shutterstock Inc. will pay $35 million to resolve the Federal Trade Commission's lawsuit alleging it knowingly deceived customers about its subscription plans' autorenewal policies, with one executive noting in internal communications they could "hopefully get away with it" when they saw competitor Adobe Inc. sued over its subscription practices in 2024.

  • May 13, 2026

    Split 6th Circ. Affirms $1 Damages In Touch Screen Tech Case

    A split panel of the Sixth Circuit has upheld a $1 damages award that a Michigan federal judge gave to electronics manufacturer Oldnar Corp., with two judges saying they agreed that Oldnar had not proved higher damages with reasonable certainty.

Expert Analysis

  • Justices May Hesitate To Limit Courts' Arbitration Review

    Author Photo

    Based on Monday's argument in Jules v. Andre Balazs, the U.S. Supreme Court seems poised to preserve federal jurisdiction over arbitral award enforcement stemming from actions originated in federal court, a holding that would markedly limit the court's 2022 Walters v. Badgerow decision, says Ashwini Jayaratnam at DarrowEverett.

  • Series

    Ultramarathons Make Me A Better Lawyer

    Author Photo

    Completing a 100-mile ultramarathon was tougher, more humbling and more rewarding than I ever imagined, and the experience highlighted how long-distance running has sharpened my ability to adapt to the evolving nature of antitrust law and strengthened my resolve to handle demanding, unforeseen challenges, says Dan Oakes at Axinn.

  • Determining When Engineered Biologics May Be Patentable

    Author Photo

    The Federal Circuit's recent decision in Regenxbio v. Sarepta, concluding that engineered cells with DNA from different organisms are not patent-ineligible natural phenomena, raises questions surrounding what framework courts will use to evaluate the patent eligibility of engineered biologics moving forward, says Robert Frederickson at Goodwin.

  • Getting The Most Out Of Learning And Development Programs

    Excerpt from Practical Guidance
    Author Photo

    Junior associates can better develop the legal, business and interpersonal skills they need for long-term success by approaching their firms’ learning and development programs armed with five tips for getting the most out of these resources, says Lauren Hakala at Reed Smith.

  • A Shift In Fed. Circ.'s Approach To Patent Summary Judgment

    Author Photo

    The Federal Circuit's recent decision in Range of Motion v. Armaid may come to be seen as a seminal opinion for potentially exposing and entrenching the Federal Circuit's movement away from its previous framework for identifying obvious noninfringement cases, says Nicholas Nowak at Nowak IP Group.

  • Considering The Risks That Arise When IP Outlives Its Owner

    Author Photo

    Federal and state court decisions show that the statutory regime for each category of intellectual property promises continuity after the owner's death, but the law does not provide a succession framework for how those rights are to be exercised, says Erin Daly at Daly Law & Strategy.

  • How A High Court Music Piracy Ruling Shrinks ISP Liability

    Author Photo

    The U.S. Supreme Court's recent opinion in Cox Communications Inc. v. Sony Music Entertainment, which concerned the boundaries of contributory copyright infringement for internet service providers, dramatically lessens both the risk that an ISP will be held contributorily liable and, relatedly, the incentives an ISP may have to help combat online copyright infringement, say attorneys at Debevoise.

  • Opinion

    AI Presents A Make-Or-Break Moment For Outside Counsel

    Author Photo

    The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.

  • Opinion

    USPTO Has A Chance To Correct Double-Patenting Doctrine

    Author Photo

    Now that the issue of obviousness-type double patenting is front and center before the U.S. Patent and Trademark Office's Appeals Review Panel, the agency should put an end to the practice of rejecting earlier-expiring patents in favor of later-expiring ones, say attorneys at Orrick.

  • 1st AI Acquisition Regulation Raises Contractor Concerns

    Author Photo

    The General Services Administration’s recently published contract clause addressing artificial intelligence systems is problematic in a number of ways, underscoring the complex legal and practical issues that will need to be addressed as AI becomes more widely deployed in federal contracting, say attorneys at Haynes Boone.

  • Grammarly Suit Flags Right Of Publicity As Key AI Issue

    Author Photo

    Angwin v. Superhuman Platform, filed recently in New York federal court against the parent company of Grammarly, highlights an overlooked question for any company using artificial intelligence — whether someone's identity has been used for commercial purposes without consent, possibly violating rapidly shifting state right-of-publicity laws, says Nicholas Schneider at Eckert Seamans.

  • Series

    Watching Hallmark Movies Makes Me A Better Lawyer

    Author Photo

    I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.

  • Reel Justice: 'Mercy' And Private Surveillance As Evidence

    Author Photo

    The near-future depicted in the film “Mercy” reminds attorneys that private surveillance networks are becoming central to the evidentiary ecosystem, shaping what prosecutors can obtain, what defendants must explain and what jurors may interpret as objective truth, says Veronica Finkelstein at Wilmington University.

  • Fed. Circ. In February: When Grammar Trumps Patent Specs

    Author Photo

    The Federal Circuit's decision in Netflix v. DivX last month highlights the challenge of interpreting potentially misplaced modifiers in complicated technological patents, and the potential for grammatical rules to provide a default interpretation for unclear claim language, say attorneys at Knobbe Martens.

  • New Orphan Drug Law Provides A Key Fix For Pharma Cos.

    Author Photo

    The Consolidated Appropriations Act enacted last month restores the U.S. Food and Drug Administration's long-standing interpretation of "same disease or condition," related to orphan drug exclusivity, resolving years of regulatory uncertainty and litigation that have discouraged rare disease research, say attorneys at Spencer Fane.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.